The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin

Molecular Imaging and Biology

Volumn 7, Issue 3, 2005, Pages 236-243

  Scott, Clare L ^a   Kudaba, Iveta ^a   Stewart, Josephine M ^a   Hicks, Rodney J ^a,b   Rischin, Danny ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Positron emission tomography; Review; Unknown primary tumor

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISSEMINATED CANCER; ESOPHAGUS CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; KIDNEY CANCER; LUNG CANCER; MALE; MEDICAL RECORD; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; TREATMENT PLANNING; TUMOR LOCALIZATION; CARCINOMA; FOLLOW UP; MIDDLE AGED; NEOPLASM; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES;

EID: 24744446492     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11307-005-4114-x     Document Type: Article

References (23)

1. U Lassen G Daugaard A Eigtved K Damgaard L Friberg 1999 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumors (UPT) Eur J Cancer 35 1076-1082 10.1016/S0959-8049(99)00077-5 1:STN:280:DC%2BD3c%2FgtlKntg%3D%3D 10533451
2. N Pavlidis E Briasoulis J Hainsworth FA Greco 2003 Diagnostic and therapeutic management of cancer of an unknown primary Eur J Cancer 39 1990-2005 10.1016/S0959-8049(03)00547-1 1:STN:280:DC%2BD3svhslyrsA%3D%3D 12957453
3. D Rades G Kuhnel I Wildfang AR Borner HJ Schmoll W Knapp 2001 Localized disease in cancer of unknown primary (CUP): The value of positron emission tomography (PET) for individual therapeutic management Ann Oncol 12 1605-1609 10.1023/A:1013107732572 1:STN:280:DC%2BD38%2FptlGhsQ%3D%3D 11822762
4. JH McMillan E Levine RH Stephens 1982 Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site. A retrospective study Radiology 143 143-146 1:STN:280:Bi2C2M7otlM%3D 7063718
5. GB Fogarty LJ Peters J Stewart C Scott D Rischin RJ Hicks 2003 The usefulness of fluorine 18-labeled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor Head Neck 25 138-145 10.1002/hed.10191 12509797
6. AC Kole OE Nieweg J Pruim et al. 1998 Detection of unknown occult primary tumors using positron emission tomography Cancer 82 1160-1166 10.1002/(SICI)1097-0142(19980315)82:6<1160::AID-CNCR22>3.0.CO;2-3 1:STN:280:DyaK1c7msFWrtQ%3D%3D 9506364
7. KH Bohuslavizki S Klutmann S Kroger et al. 2000 FDG PET detection of unknown primary tumors J Nucl Med 41 816-822 1:STN:280:DC%2BD3c3mslWqtg%3D%3D 10809197
8. M Lonneux A Reffad 2000 Metastases from unknown primary tumor. PET-FDG as initial diagnostic procedure? Clin Positron Imaging 3 137-141 10.1016/S1095-0397(00)00053-4 11150745
9. P Mantaka RP Baum A Hertel et al. 2003 PET with 2-[F-18]-fluoro-2-deoxy- D-glucose (FDG) in patients with cancer of unknown primary (CUP): Influence on patients' diagnostic and therapeutic management Cancer Biother Radiopharm 18 47-58 10.1089/108497803321269322 12667308
10. JL Alberini T Belhocine R Hustinx F Daenen P Rigo 2003 Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumors (CUP syndrome) Nucl Med Commun 24 1081-1086 10.1097/00006231-200310000-00008 1:STN:280:DC%2BD3svkslKjtg%3D%3D 14508164
11. LG Strauss PS Conti 1991 The applications of PET in clinical oncology J Nucl Med 32 138-145
12. WJ Scott JL Schwabe NC Gupta NA Dewan SD Reeb JT Sugimoto 1994 Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The members of the PET-Lung Tumor Study Group Ann Thorac Surg 58 698-703 1:STN:280:ByqD3s7jvVQ%3D 7944691
13. K Scheidhauer A Scharl U Pietrzyk et al. 1996 Qualitative [18F]FDG positron emission tomography in primary breast cancer: Clinical relevance and practicability Eur J Nucl Med 23 618-623 10.1007/ BF00834522 1:STN:280:BymB28bpsFY%3D 8662094
14. WD Holder Jr RL White Jr JH Zuger EJ Easton FL Greene 1998 Effectiveness of positron emission tomography for the detection of melanoma metastases Ann Surg 227 764-769 10.1097/00000658-199805000-00017 9605668
15. M Rodriguez S Rehn H Ahlstrom C Sundstrom B Glimelius 1995 Predicting malignancy grade with PET in non-Hodgkin's lymphoma J Nucl Med 36 1790-1796 1:STN:280:BymD3cjmt1M%3D 7562044
16. G Beets F Penninckx C Schiepers et al. 1994 Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer Br J Surg 81 1666-1670 1:STN:280:ByqC38fntVM%3D 7827902
17. RE Coleman 1998 Clinical PET in oncology Clin Positron Imaging 1 15-30 10.1016/S1095-0397(97)00004-6 14516605
18. JS Nystrom JM Weiner J Heffelfinger-Juttner LE Irwin JR Bateman RM Wolf 1977 Metastatic and histologic presentations in unknown primary cancer Semin Oncol 4 53-58 1:STN:280:CSiC38jjvFE%3D 841350
19. J Klastersky M Paesmans 2001 Response to chemotherapy, quality of life benefits and survival in advanced non-small cell lung cancer: Review of literature results Lung Cancer 34 S95-S101 10.1016/S0169-5002(01)00383-X
20. HA Burris III MJ Moore J Andersen et al. 1997 Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial J Clin Oncol 15 2403-2413 1:CAS:528:DyaK2sXlsFKksLY%3D 9196156
21. FA Greco 2001 Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer Lung Cancer 34 S53-S56 10.1016/ S0169-5002(01)00393-2
22. N Thatcher 2001 Chemotherapy for advanced non-small cell lung cancer Lung Cancer 34 S171-S175 10.1016/S0169-5002(01)00364-6 11720761 S171-S175 11720761
23. PF Macgregor JA Squire 2002 Application of microarrays to the analysis of gene expression in cancer Clin Chem 48 1170-1177 1:CAS:528:DC%2BD38XlslKksLY%3D 12142369